CD14-159C/T and TLR9-1237T/C polymorphisms are not associated with gastric cancer risk in Caucasian populations

Host genetic factors play an important role in modifying the risk of human disease, including cancers of the upper gastrointestinal tract, with increasing interest in Toll-like receptor (TLR) signaling and the impact of genetic polymorphisms in these systems. The CD14-159C/T and the TLR9-1237T/C promoter polymorphisms have previously been shown to be associated with various inflammatory conditions including Helicobacter pylori-induced gastritis in Caucasian populations. In this study, we assessed the association of these two functional single nucleotide polymorphisms with gastric cancer in two independent Caucasian population-based case–control studies of upper gastrointestinal tract cancer, initially in 312 noncardia gastric carcinoma cases and 419 controls and then in 184 noncardia gastric carcinomas, 123 cardia carcinomas, 159 esophageal cancers, and 211 frequency-matched controls. Odds ratios were computed from logistic models and adjusted for potential confounding factors. No significant association was found between the CD14-159C/T and the TLR9-1237T/C promoter polymorphisms and increased risk of gastric cancer. Neither single nucleotide polymorphism has been assessed in a Caucasian gastric cancer case–control study before; although the CD14-159C/T polymorphism has been reported to show no apparent association with H. pylori-related gastric malignancy in a Taiwanese Chinese population. In conclusion, although our earlier preliminary studies suggested that the CD14-159C/T and the TLR9-1237T/C promoter polymorphisms increase the risk of precancerous outcomes, they do not seem to increase the risk of gastric cancer itself. This discrepancy merits further examination.

[1]  F. Canzian,et al.  The interleukin-8-251*T/*A polymorphism is not associated with risk for gastric carcinoma development in a Portuguese population , 2008, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[2]  E. El-Omar,et al.  A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors. , 2007, Gastroenterology.

[3]  S. Kim.  A Functional Polymorphism of Toll-like Receptor 4 Gene Increases Risk of Gastric Carcinoma and Its Precursors. Gastroenterology 2007;132:905-12 , 2007 .

[4]  Ming-Tsan Lin,et al.  Functional polymorphisms of CD14 and toll-like receptor 4 in Taiwanese Chinese with Helicobacter pylori-related gastric malignancies. , 2006, Hepato-gastroenterology.

[5]  L. Hou,et al.  Interleukin-8 Polymorphisms Are Not Associated with Gastric Cancer Risk in a Polish Population , 2006, Cancer Epidemiology Biomarkers & Prevention.

[6]  M. Plummer,et al.  Polymorphisms in Genes Related to Bacterial Lipopolysaccharide/Peptidoglycan Signaling and Gastric Precancerous Lesions in a Population at High Risk for Gastric Cancer , 2006, Digestive Diseases and Sciences.

[7]  T. Mussack,et al.  Polymorphisms of the lipopolysaccharide-signaling complex in inflammatory bowel disease: association of a mutation in the Toll-like receptor 4 gene with ulcerative colitis. , 2004, Clinical immunology.

[8]  H. Drummond,et al.  NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: evidence for genetic heterogeneity within Europe? , 2004, Genes and Immunity.

[9]  H. Müller-Hermelink,et al.  Expression and subcellular distribution of toll‐like receptors TLR4, TLR5 and TLR9 on the gastric epithelium in Helicobacter pylori infection , 2004, Clinical and experimental immunology.

[10]  E. El-Omar,et al.  A functional toll-like receptor 4 polymorphism increases risk of H. pylori-induced premalignant changes , 2003 .

[11]  A. Hobson,et al.  The prostaglandin E2 receptor-1 (EP-1) mediates acid-induced visceral pain hypersensitivity in humans. , 2003, Gastroenterology.

[12]  Xuetao Cao,et al.  Up-regulation of TLR9 gene expression by LPS in mouse macrophages via activation of NF-kappaB, ERK and p38 MAPK signal pathways. , 2002, Immunology letters.

[13]  S. Akira,et al.  Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[14]  D. Postma,et al.  Association of a promoter polymorphism of the CD14 gene and atopy. , 2001, American journal of respiratory and critical care medicine.

[15]  S. Akira,et al.  A Toll-like receptor recognizes bacterial DNA , 2000, Nature.

[16]  M. Carrington,et al.  Interleukin-1 polymorphisms associated with increased risk of gastric cancer , 2000, Nature.

[17]  G. Schmitz,et al.  C(-260)-->T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. , 1999, Circulation.

[18]  P. Holt,et al.  A Polymorphism* in the 5' flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. , 1999, American journal of respiratory cell and molecular biology.

[19]  L. Sobin,et al.  Risk of stomach cancer in relation to consumption of cigarettes, alcohol, tea and coffee in Warsaw, Poland. , 1999, International journal of cancer.

[20]  M. Gammon,et al.  Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. , 1997, Journal of the National Cancer Institute.